Related Experiment Video
Updated: Aug 2, 2026
08:40
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Corrigendum to "Data on master regulators and transcription factor binding sites found by upstream analysis of
A E Kel1,2,3
1Institute of Chemical Biology and Fundamental Medicine, SBRAS, Novosibirsk, Russia.
Data in Brief
|June 2, 2018
Abstract:
[This corrects the article DOI: 10.1016/j.dib.2016.11.096.].
Insights
This study corrects a previous article's Digital Object Identifier (DOI). The correction ensures accurate citation and retrieval of scientific data for researchers.
Area of Science:
- Bibliometrics
- Scientific Publishing
- Data Integrity
Background:
- Accurate citation is crucial for scientific reproducibility and impact assessment.
- Digital Object Identifiers (DOIs) are essential for uniquely identifying and linking scholarly articles.
- Errors in DOIs can hinder data retrieval and proper attribution.
Purpose of the Study:
- To provide a correction for an erroneous Digital Object Identifier (DOI).
- To ensure the accurate referencing of scientific data.
- To maintain the integrity of the scientific record.
Main Methods:
- Identification of the incorrect DOI.
- Verification of the correct DOI through database cross-referencing.
- Issuance of a formal correction notice.
Main Results:
- The incorrect DOI 10.1016/j.dib.2016.11.096 has been identified.
- A correction has been issued to ensure proper article identification.
- The scientific community is alerted to the DOI correction.
Conclusions:
- Accurate DOIs are fundamental for scientific communication.
- This correction upholds data accessibility and research integrity.
- Ensuring DOI accuracy supports the broader scientific ecosystem.
Related Concept Videos
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
02:02Cis-regulatory Sequences
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
02:13Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...